Precision Biosciences Inc
Nasdaq · Healthcare · Biological Products, (No Diagnostic Substances) · Durham, NC
DTIL chart
What traders are saying about $DTIL
Latest postsPrecision Biosciences Inc news
- Precision BioSciences Inc (PBS0.MU) stock price, news, quote and history
Yahoo Finance UK ·
- Precision BioSciences Announces Late-Breaking Oral Presentation for PBGENE-HBV at AASLD The Liver Meeting 2026
Yahoo Finance ·
- Gene-Editing Powerhouse And Its Rivals Surge Toward A Breakout
Yahoo Finance ·
- Precision BioSciences Commences Dosing in Phase 1/2 FUNCTION-DMD Study
Yahoo Finance ·
- Precision BioSciences Reports Second Quarter 2026 Financial Results and Provides Business Update
Yahoo Finance ·
- Precision BioSciences to Report Second Quarter 2026 Financial Results on August 6, 2026
Yahoo Finance ·
- Precision BioSciences Announces Changes to Senior Leadership Team to Support Advancement of Programs Through Next Set of Clinical Milestones
Yahoo Finance ·
- Precision BioSciences Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance ·
- Strength Seen in Precision BioSciences (DTIL): Can Its 12.3% Jump Turn into More Strength?
Yahoo Finance ·
- Precision BioSciences Announces Inclusion in the Russell 2000® Index Expanding Market Visibility with Institutional Investors
Yahoo Finance ·
- [Latest] Global Genome Editing Market Size/Share Worth USD 55.7 Billion by 2035 at a 17.4% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)
Yahoo Finance ·
- Bullish: Analysts Just Made A Notable Upgrade To Their Precision BioSciences, Inc. (NASDAQ:DTIL) Forecasts
Yahoo Finance ·
Precision Biosciences Inc key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $34.3M | $68.7M | $48.7M | $25.1M |
| Net income | -$45.7M | $7.2M | -$61.3M | -$111.6M |
| Diluted EPS | $-3.56 | $1.04 | $-15.96 | $-38.10 |
| Total assets (year end) | $154.4M | $136.4M | $159.8M | $238.2M |
| Cash and equivalents (year end) | $110.8M | $85.9M | $116.7M | $189.6M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Precision Biosciences Inc
- Ticker
- DTIL (Nasdaq)
- Industry
- Biological Products, (No Diagnostic Substances)
- Headquarters
- Durham, NC
- Incorporated in
- DE
- Fiscal year end
- May 21
- SEC CIK
- 1357874
Frequently asked questions
What exchange is Precision Biosciences Inc listed on?
Precision Biosciences Inc trades on the Nasdaq under the ticker symbol DTIL.
What industry is Precision Biosciences Inc in?
Precision Biosciences Inc is classified by the SEC under "Biological Products, (No Diagnostic Substances)", part of the Healthcare sector on StockTweeting.
Where is Precision Biosciences Inc headquartered?
Precision Biosciences Inc's business address on file with the SEC is in Durham, NC.
When does Precision Biosciences Inc's fiscal year end?
Precision Biosciences Inc's fiscal year ends on May 21.
How much revenue did Precision Biosciences Inc report?
Precision Biosciences Inc reported $34.3M in revenue for calendar year 2025, according to its SEC filings.